Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Tofacitinib Nasal Spray for Treatment-Resistant Chronic Rhinosinusitis with Polyps
IRCT20260310068980N1Phase 2Recruiting
- Sponsor
- Iran University of Medical Sciences
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of tofacitinib in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by Iran University of Medical Sciences. Started Mar 2026; status: recruiting.
02
Drugs
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on IRCT20260310068980N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260310068980N1.